Figures & data
Table 1. The comparison of particle sizes, zeta potential values and encapsulation efficiency (%EE) of PLGA nanospheres loaded with papain prepared by the ESD and ESE methods.
Figure 1. The scanning electron (A) and transmission electron (B) microphotographs of PLGA nanospheres (composed of 100 mg PLGA and 10%w/v PVA403) loaded with 43 µg papain/mg PLGA nanospheres prepared by the ESE method (12000X).
![Figure 1. The scanning electron (A) and transmission electron (B) microphotographs of PLGA nanospheres (composed of 100 mg PLGA and 10%w/v PVA403) loaded with 43 µg papain/mg PLGA nanospheres prepared by the ESE method (12000X).](/cms/asset/c93b189e-3438-43f1-a597-42a5f1f79dc1/tjen_a_636385_o_f0001g.gif)
Figure 2. Comparision of profile release of papain loaded in PLGA nanospheres prepared by ESD (emulsion solvent diffusion method in water) and ESE (w/o/w emulsion solvent evaporation method) in 0.2 M phosphate buffer (pH 7.0) solution at 27 ± 2°C.
![Figure 2. Comparision of profile release of papain loaded in PLGA nanospheres prepared by ESD (emulsion solvent diffusion method in water) and ESE (w/o/w emulsion solvent evaporation method) in 0.2 M phosphate buffer (pH 7.0) solution at 27 ± 2°C.](/cms/asset/41810a69-eee2-476d-bad9-8d498cc23e5f/tjen_a_636385_o_f0002g.gif)
Table 2. Release kinetics of papain from the PLGA nanospheres prepared by the ESD and ESE method in 0.2 M phosphate buffer (pH 7.0) solution at 27 ± 2°C to 48 h.
Figure 3. The percentages of human skin fibroblast viability by the SRB assay of (A) the unloaded nanospheres and (B) the PLGA nanospheres loaded with papain prepared by the ESD (emulsion solvent diffusion in water) method (19 µg papain/mg PLGA nanosphere) and the ESE (w/o/w emulsion solvent evaporation) method (43 µg papain/mg PLGA nanosphere).
![Figure 3. The percentages of human skin fibroblast viability by the SRB assay of (A) the unloaded nanospheres and (B) the PLGA nanospheres loaded with papain prepared by the ESD (emulsion solvent diffusion in water) method (19 µg papain/mg PLGA nanosphere) and the ESE (w/o/w emulsion solvent evaporation) method (43 µg papain/mg PLGA nanosphere).](/cms/asset/376bff6c-714f-4f65-b859-5a72ffdeef4a/tjen_a_636385_o_f0003g.gif)
Figure 4. The percentages remaining of the unloaded papain and loaded in PLGA nanospheres prepared by the ESE (w/o/w emulsion solvent evaporation) method stored at different temperatures (25 ± 2, 4 ± 2 and 45 ± 2°C) for 6 weeks; Pn-4: papain loaded in PLGA nanospheres kept at 4°C; Pn-25: papain loaded in PLGA nanospheres kept at 25°C; Pn-45: papain loaded in PLGA nanospheres kept at 45°C; Ps-4: papain solution in 0.2 M phosphate buffer (pH 5.0) kept at 4°C; Ps-25: papain solution in 0.2 M phosphate buffer (pH 5.0) kept at 25°C and Ps-45: papain solution in 0.2 M phosphate buffer (pH 5.0) kept at 45°C.
![Figure 4. The percentages remaining of the unloaded papain and loaded in PLGA nanospheres prepared by the ESE (w/o/w emulsion solvent evaporation) method stored at different temperatures (25 ± 2, 4 ± 2 and 45 ± 2°C) for 6 weeks; Pn-4: papain loaded in PLGA nanospheres kept at 4°C; Pn-25: papain loaded in PLGA nanospheres kept at 25°C; Pn-45: papain loaded in PLGA nanospheres kept at 45°C; Ps-4: papain solution in 0.2 M phosphate buffer (pH 5.0) kept at 4°C; Ps-25: papain solution in 0.2 M phosphate buffer (pH 5.0) kept at 25°C and Ps-45: papain solution in 0.2 M phosphate buffer (pH 5.0) kept at 45°C.](/cms/asset/4c86bf51-6c4f-4c50-9785-50aecf04134c/tjen_a_636385_o_f0004g.gif)